Redcare Pharmacy NV (RDC) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Redcare Pharmacy NV stock €13.36, price €66.50, that is 79.9% below the price, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Redcare Pharmacy NV
RDC · XETRAFar too expensive (fair value 80% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range €30.86 – €170.50 · fair‑value band €6.02 – €20.70 · the €66.50 price screens above the €13.36 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Redcare Pharmacy is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements.
Show moreShow less
The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands.
Stock analysis
Redcare Pharmacy NV (RDC) currently trades at €66.50, while our model-based Fair Value estimate is €13.36, 80% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 94/100, which puts the data coverage at low.
Scenario range: €6.02 (bear) to €20.70 (bull), the price of €66.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Redcare Pharmacy NV reported revenue of €2.9B in FY2025 versus €1.1B in FY2021, a compound +29.1%/yr. Reported net income was −€37.7M in FY2025.
Key figures
Market cap €1.3B Small · P/S ratio 0.41 · EPS (TTM) €−1.69 · Net margin −1.0% · Return on equity −7.1% · Return on assets (EBIT) −5.1% (5-year average) · Operating margin 0.3% · Revenue (TTM) €3.3B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 15 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and 115% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 19% fair-value upside, at −80%, RDC screens richer than that median.
Fair Value models
All 2 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
RDC screens overvalued: fair value 80% below the price. Compare with JD Health International Inc →
Earlier news
- Redcare Pharmacy (XTRA:RDC) Stock May Be Priced Richly After A 47% Five Year Fall
- Redcare Pharmacy Raises Full-year 2026 Revenue Guidance Again, Driven by Strong Rx Momentum in Germany
- Redcare Pharmacy NV (SHPPF) (Q2 2026) Earnings Call Highlights: Revenue Growth Guidance Raised ...
- Change in Redcare Pharmacy's Managing Board: New CFO Hendrik Krampe
Compare Redcare Pharmacy NV with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 54 stocks
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: German Stocks
- Valuation of the Germany market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| JD Health International Inc 6618 | HK$34.86 | HK$75.43 | +116% | vs RDC |
| Yifeng Pharmacy Chain Co 603939 | ¥26.65 | ¥40.59 | +52% | vs RDC |
| Yixintang Pharmaceutical Group 002727 | ¥13.48 | ¥18.92 | +40% | vs RDC |
| DaShenLin Pharmaceutical Group 603233 | ¥20.71 | ¥25.52 | +23% | vs RDC |
| Nahdi Medical Company 4164 | 95.25 SAR | 113.21 SAR | +19% | vs RDC |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥14.91 | ¥16.40 | +10% | vs RDC |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥12.59 | ¥13.85 | +10% | vs RDC |
| DocMorris AG DOCM | CHF 18.00 | CHF 15.17 | −16% | vs RDC |
| ShuYu Civilian Pharmacy Corp 301017 | ¥11.92 | ¥5.91 | −50% | vs RDC |
| Apotea AB APOTEA | kr 101.30 | kr 39.50 | −61% | vs RDC |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Redcare Pharmacy NV (RDC) overvalued or undervalued?
What is the fair value of RDC?
What is the quality score of RDC?
What is the price target for Redcare Pharmacy NV (RDC)?
What is the Redcare Pharmacy NV stock forecast for 2026?
What is the revenue of Redcare Pharmacy NV (RDC)?
What is the intrinsic value of Redcare Pharmacy NV (RDC)?
Is Redcare Pharmacy NV stock overvalued or undervalued in 2026?
Is fair value the same as the market price of RDC?
How much is Redcare Pharmacy NV worth?
What do the bullish and bearish scenarios say about RDC?
How solid is the balance sheet of Redcare Pharmacy NV (RDC)?
How far is RDC from its 52-week high?
Which stocks are comparable to Redcare Pharmacy NV?
Is Redcare Pharmacy NV stock attractive at the current price?
How is the fair value of RDC calculated?
Is it still worth investing in stocks now?
What is the share price of Redcare Pharmacy NV (RDC)?
What should I pay attention to with Redcare Pharmacy NV right now?
Key figures of Redcare Pharmacy NV
How large is the market capitalisation of Redcare Pharmacy NV (RDC)?
What is the P/S ratio of Redcare Pharmacy NV (RDC)?
What are the earnings per share of Redcare Pharmacy NV (RDC)?
What is the net margin of Redcare Pharmacy NV (RDC)?
What is the return on equity of Redcare Pharmacy NV (RDC)?
What is the EBIT return on assets of Redcare Pharmacy NV (RDC)?
What is the operating margin of Redcare Pharmacy NV (RDC)?
How fast is revenue growing at Redcare Pharmacy NV (RDC)?
How fast are earnings growing at Redcare Pharmacy NV (RDC)?
How much free cash flow does Redcare Pharmacy NV (RDC) generate?
How much net debt does Redcare Pharmacy NV (RDC) carry?
Watch Redcare Pharmacy NV in the live analysis
One click puts Redcare Pharmacy NV on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.